These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 15323553

  • 1. Membrane-insertion fragments of Bcl-xL, Bax, and Bid.
    García-Sáez AJ, Mingarro I, Pérez-Payá E, Salgado J.
    Biochemistry; 2004 Aug 31; 43(34):10930-43. PubMed ID: 15323553
    [Abstract] [Full Text] [Related]

  • 2. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.
    Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR.
    Science; 2004 Feb 13; 303(5660):1010-4. PubMed ID: 14963330
    [Abstract] [Full Text] [Related]

  • 3. Investigation of the role of the C-terminus of Bax and of tc-Bid on Bax interaction with yeast mitochondria.
    Priault M, Cartron PF, Camougrand N, Antonsson B, Vallette FM, Manon S.
    Cell Death Differ; 2003 Sep 13; 10(9):1068-77. PubMed ID: 12934081
    [Abstract] [Full Text] [Related]

  • 4. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis.
    Annis MG, Soucie EL, Dlugosz PJ, Cruz-Aguado JA, Penn LZ, Leber B, Andrews DW.
    EMBO J; 2005 Jun 15; 24(12):2096-103. PubMed ID: 15920484
    [Abstract] [Full Text] [Related]

  • 5. BID-dependent and BID-independent pathways for BAX insertion into mitochondria.
    Ruffolo SC, Breckenridge DG, Nguyen M, Goping IS, Gross A, Korsmeyer SJ, Li H, Yuan J, Shore GC.
    Cell Death Differ; 2000 Nov 15; 7(11):1101-8. PubMed ID: 11139284
    [Abstract] [Full Text] [Related]

  • 6. Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.
    Roucou X, Montessuit S, Antonsson B, Martinou JC.
    Biochem J; 2002 Dec 15; 368(Pt 3):915-21. PubMed ID: 12193163
    [Abstract] [Full Text] [Related]

  • 7. Distinct domains of Bcl-XL are involved in Bax and Bad antagonism and in apoptosis inhibition.
    Zhou H, Hou Q, Chai Y, Hsu YT.
    Exp Cell Res; 2005 Oct 01; 309(2):316-28. PubMed ID: 16061221
    [Abstract] [Full Text] [Related]

  • 8. Cardiolipin provides specificity for targeting of tBid to mitochondria.
    Lutter M, Fang M, Luo X, Nishijima M, Xie X, Wang X.
    Nat Cell Biol; 2000 Oct 01; 2(10):754-61. PubMed ID: 11025668
    [Abstract] [Full Text] [Related]

  • 9. Structural biology of the Bcl-2 family of proteins.
    Petros AM, Olejniczak ET, Fesik SW.
    Biochim Biophys Acta; 2004 Mar 01; 1644(2-3):83-94. PubMed ID: 14996493
    [Abstract] [Full Text] [Related]

  • 10. Peptides derived from apoptotic Bax and Bid reproduce the poration activity of the parent full-length proteins.
    García-Sáez AJ, Coraiola M, Dalla Serra M, Mingarro I, Menestrina G, Salgado J.
    Biophys J; 2005 Jun 01; 88(6):3976-90. PubMed ID: 15778450
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
    Schmitt E, Paquet C, Beauchemin M, Dever-Bertrand J, Bertrand R.
    Biochem Biophys Res Commun; 2000 Apr 21; 270(3):868-79. PubMed ID: 10772918
    [Abstract] [Full Text] [Related]

  • 12. Transbilayer lipid diffusion promoted by Bax: implications for apoptosis.
    Epand RF, Martinou JC, Montessuit S, Epand RM.
    Biochemistry; 2003 Dec 16; 42(49):14576-82. PubMed ID: 14661970
    [Abstract] [Full Text] [Related]

  • 13. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
    Yin H, Lee GI, Sedey KA, Kutzki O, Park HS, Orner BP, Ernst JT, Wang HG, Sebti SM, Hamilton AD.
    J Am Chem Soc; 2005 Jul 27; 127(29):10191-6. PubMed ID: 16028929
    [Abstract] [Full Text] [Related]

  • 14. Bid: a Bax-like BH3 protein.
    Billen LP, Shamas-Din A, Andrews DW.
    Oncogene; 2008 Dec 27; 27 Suppl 1():S93-104. PubMed ID: 19641510
    [Abstract] [Full Text] [Related]

  • 15. Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers.
    Jeong SY, Gaume B, Lee YJ, Hsu YT, Ryu SW, Yoon SH, Youle RJ.
    EMBO J; 2004 May 19; 23(10):2146-55. PubMed ID: 15131699
    [Abstract] [Full Text] [Related]

  • 16. Bcl-xES, a BH4- and BH2-containing antiapoptotic protein, delays Bax oligomer formation and binds Apaf-1, blocking procaspase-9 activation.
    Schmitt E, Paquet C, Beauchemin M, Bertrand R.
    Oncogene; 2004 May 13; 23(22):3915-31. PubMed ID: 15048082
    [Abstract] [Full Text] [Related]

  • 17. The C-terminus of bax is not a membrane addressing/anchoring signal.
    Tremblais K, Oliver L, Juin P, Le Cabellec TM, Meflah K, Vallette FM.
    Biochem Biophys Res Commun; 1999 Jul 14; 260(3):582-91. PubMed ID: 10403809
    [Abstract] [Full Text] [Related]

  • 18. Structural model of the BCL-w-BID peptide complex and its interactions with phospholipid micelles.
    Denisov AY, Chen G, Sprules T, Moldoveanu T, Beauparlant P, Gehring K.
    Biochemistry; 2006 Feb 21; 45(7):2250-6. PubMed ID: 16475813
    [Abstract] [Full Text] [Related]

  • 19. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L).
    Vieira HL, Boya P, Cohen I, El Hamel C, Haouzi D, Druillenec S, Belzacq AS, Brenner C, Roques B, Kroemer G.
    Oncogene; 2002 Mar 27; 21(13):1963-77. PubMed ID: 11960369
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria.
    Arnoult D, Bartle LM, Skaletskaya A, Poncet D, Zamzami N, Park PU, Sharpe J, Youle RJ, Goldmacher VS.
    Proc Natl Acad Sci U S A; 2004 May 25; 101(21):7988-93. PubMed ID: 15148411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.